The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors influencing outcomes in patients (Pts) with relapsed/refractory b-precursor acute lymphoblastic leukemia (r/r ALL) treated with blinatumomab in a phase 2 study.
 
Hagop Kantarjian
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Nicola Gökbuget
Consulting or Advisory Role - Amgen; Pfizer
Speakers' Bureau - Amgen; Pfizer
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen; Pfizer
 
Susan Mary O'Brien
No Relationships to Disclose
 
Anthony Selwyn Stein
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Research Funding - Amgen
 
Catherine Jia
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Stephen J. Forman
Research Funding - Amgen (Inst)
 
Ralf C. Bargou
Honoraria - Amgen; Novartis; Pfizer
Consulting or Advisory Role - Amgen; Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - Amgen
 
Adele K. Fielding
Consulting or Advisory Role - Amgen
Research Funding - Sigma-Tau
 
Leonard T. Heffner
Honoraria - Amgen
Research Funding - Amgen (Inst); Biotest (Inst); Gilead Sciences (Inst); Onyx (Inst); Pfizer (Inst); Pharmacyclics (Inst); Spectrum Pharmaceuticals (Inst)
 
Richard A. Larson
No Relationships to Disclose
 
Svenja Neumann
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Novartis
 
Tapan Maniar
Employment - Amgen
 
Dirk Nagorsen
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Amgen
 
Max S. Topp
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Patents, Royalties, Other Intellectual Property - Amgen
Travel, Accommodations, Expenses - Amgen; Roche Pharma AG; Takeda